Substance Abuse, Addiction, and Treatment: Global Markets

  • ID: 4392753
  • Report
  • 150 Pages
  • BCC Research
15 % OFF
until Jun 30th 2018
1 of 6
The Global Substance Abuse and Addiction Treatment Market Should Reach Nearly $4.4 billion in 2021, at a CAGR of 7.0%

FEATURED COMPANIES

  • Alkermes Plc
  • Cipla Limited
  • Glaxosmithkline Plc (Gsk)
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer Inc.
  • MORE

Report Includes

  • An overview of the global market for substance abuse and addiction treatment therapeutics
  • Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021
  • Analyses of the market based on condition, treatment type, and region
  • Discussion of the market dynamics, including drivers, restraints and opportunities
  • An insight into the competitive landscape of the market through new product launches, mergers and acquisitions, and partnerships
  • Profiles of the key players in the market

Report Scope

This report presents an in-depth analysis of the global substance abuse and addiction treatment market by conditions, treatments, and geographic markets; it includes the principal drug abuse conditions that are incorporated into several therapeutic treatment methods. This report examines the role of supply-chain members from manufacturers to researchers, and contains a comprehensive analysis of the dominant companies operating in the global substance abuse and addiction treatment market. The in-depth patent analysis section of the report will focus extensively on the technological trends across years and geographies such as the U.S., Europe and China.

This study considers the revenue generated by medications or therapeutics during the substance abuse treatment process. It does not review the expenses associated with services such as counseling, psychological therapy, rehabilitation or others. The report focuses on the substances that are either directly consumed or injected, hence the nicotine segment considers the medicines that help to treat smokeless tobacco addiction but does not take into account drugs that are only used for smoking cessation. The report examines all forms of opioids and cocaine in whichever form or mode they are ingested, and considers all types of alcohol abuse.

The market study is detailed for products based on applications as well as its further implication in the research and development area. These two segmentations are also discussed in depth for the given period. The market is broken down by the geographical regions of North America, Europe, Asia-Pacific and the ROW. Key market players operating in this market are Pfizer, GlaxoSmithKline, Alkermes, Teva Pharmaceuticals, Reckitt Benckiser, Forest Laboratories, and others totaling to about 20 companies.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Alkermes Plc
  • Cipla Limited
  • Glaxosmithkline Plc (Gsk)
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer Inc.
  • MORE

1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of the Report
  • Intended Audience
  • Information Sources and Methodology
  • Geographic Breakdown

2: Summary and Highlights

  • Table Summary : Global Market for Substance Abuse and Addiction Treatment, by Condition, Through 2021
  • Figure Summary : Global Market for Substance Abuse and Addiction Treatment, by Condition, 2015-2021

3: Global Substance Abuse and Addiction Treatment Market and Technology Background

  • Substance Abuse and Addiction Treatment
  • Drug Testing Laws
  • Testing Locations
  • On-site Testing Versus Laboratory Testing
  • Side Effects of Substance Abuse and Role of Drug Screening in Detection
  • Drug, Nicotine and Alcohol Abuse Trends Among Youth
  • Future Prediction of Drug Screening and Drug Abuse
  • Technology Trends
  • Government Funding for Drug Testing, Illicit Drug Use, Alcohol Use, and Other Parameters Influencing Market Growth
  • Clinical Guidelines
  • Overview of Captagon
  • Market Dynamics

4: Global Substance Abuse and Addiction Treatment Market by Condition

  • Nicotine Abuse
  • Alcohol Abuse
  • Drug Abuse
  • Table 11 : Global Market for Substance Abuse and Addiction Treatment, by Condition, Through 2021

5: Global Substance Abuse and Addiction Treatment Market by Treatment Type

  • Chantix
  • Zyban
  • Detoxification Treatment
  • Campral
  • Antabuse
  • Methadone
  • Suboxone
  • Others
  • Table 16 : Global Substance Abuse and Addiction Treatment Market, by Type, Through 2021

6: Global Substance Abuse and Addiction Treatment Market, Breakdown by Region

  • North America
  • Europe
  • Asia-Pacific
  • ROW
  • Table 25 : Global Market for Substance Abuse and Addiction Treatment, by Region, Through 2021

7: Patent Review

  • Patent Review by Year
  • Patent Review by Region
  • Patent Review by Applicant
  • Patent Review for Substance Abuse

8: Global Substance Abuse and Addiction Treatment Market Opportunities Analysis

  • Product Approval
  • Collaborations
  • Acquisitions
  • Product Launches
  • Figure 23 : Strategies for Global Substance Abuse and Addiction Treatment Market, 2014-2017

9: Company Profiles

  • Alkermes Plc
  • Allergan, Plc
  • Celtic Pharma Holdings Advisors Llp
  • Cipla Limited
  • Consern Pharma Private Limited
  • ELI Lilly And Company
  • Glaxosmithkline Plc (Gsk)
  • Intas Biopharmaceuticals
  • Johnson & Johnson
  • Mallinckrodt Pharmaceuticals
  • Medtronic
  • Novartis International AG
  • Orasure Technologies
  • Pfizer Inc.
  • Psychemedics Corporation
  • Purdue Pharma L.P.
  • Reckitt Benckiser Group Plc
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Ltd
  • Teva Pharmaceuticals Industries Limited

10: Appendix: Lists of Patents

  • List of Patents in North America
  • List of Patents in Europe
  • List of Patents in Asia-Pacific
  • List of Patents in the ROW
  • List of Abbreviations
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Alkermes Plc
  • Cipla Limited
  • Glaxosmithkline Plc (Gsk)
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer Inc.
  • MORE

Analyst Credentials

Yojana Jeevane has been writing market intelligence and business research since 2012. She has additional experience in healthcare including medical devices, the life sciences and chemicals. Ms. Jeevane holds an MBA in marketing.

Note: Product cover images may vary from those shown
5 of 6
  • Alkermes Plc
  • Allergan, Plc
  • Celtic Pharma Holdings Advisors Llp
  • Cipla Limited
  • Consern Pharma Private Limited
  • ELI Lilly And Company
  • Glaxosmithkline Plc (Gsk)
  • Intas Biopharmaceuticals
  • Johnson & Johnson
  • Mallinckrodt Pharmaceuticals
  • Medtronic
  • Novartis International AG
  • Orasure Technologies
  • Pfizer Inc.
  • Psychemedics Corporation
  • Purdue Pharma L.P.
  • Reckitt Benckiser Group Plc
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Ltd
  • Teva Pharmaceuticals Industries Limited
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll